Universal Biosensors, Inc. (UBI.AX)
AUD 0.13
(0.0%)
AUD 0.13
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.97 Million AUD | 2.95% |
| 2022 | 4.82 Million AUD | 114.05% |
| 2021 | 2.25 Million AUD | -45.77% |
| 2020 | 4.16 Million AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | -100.0% |
| 2017 | 19.02 Million AUD | -7.88% |
| 2016 | 20.65 Million AUD | 2.3% |
| 2015 | 20.19 Million AUD | 12.2% |
| 2014 | 17.99 Million AUD | 13.5% |
| 2013 | 15.85 Million AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 878.12 Thousand AUD | -14.46% |
| 2024 Q1 | 4.52 Million AUD | -8.95% |
| 2024 Q2 | 3.95 Million AUD | -12.65% |
| 2023 Q1 | 5.39 Million AUD | 11.64% |
| 2023 Q4 | 4.97 Million AUD | 12.34% |
| 2023 FY | 4.97 Million AUD | 2.95% |
| 2023 Q2 | 4.94 Million AUD | -8.22% |
| 2023 Q3 | 4.42 Million AUD | -10.56% |
| 2022 Q2 | 5.5 Million AUD | -5.35% |
| 2022 FY | 4.82 Million AUD | 114.05% |
| 2022 Q1 | 5.82 Million AUD | 158.02% |
| 2022 Q3 | 5.09 Million AUD | -7.47% |
| 2022 Q4 | 4.82 Million AUD | -5.28% |
| 2021 FY | 2.25 Million AUD | -45.77% |
| 2021 Q4 | 2.25 Million AUD | -6.16% |
| 2021 Q1 | 2.69 Million AUD | -35.25% |
| 2021 Q2 | 2.55 Million AUD | -5.3% |
| 2021 Q3 | 2.4 Million AUD | -5.76% |
| 2020 Q4 | 4.16 Million AUD | -2.9% |
| 2020 Q1 | 4.39 Million AUD | 0.0% |
| 2020 Q2 | 4.4 Million AUD | 0.15% |
| 2020 FY | 4.16 Million AUD | 0.0% |
| 2020 Q3 | 4.28 Million AUD | -2.78% |
| 2019 Q3 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 Q4 | - AUD | -100.0% |
| 2018 Q1 | 19.39 Million AUD | 1.94% |
| 2018 FY | - AUD | -100.0% |
| 2018 Q2 | 20.15 Million AUD | 3.89% |
| 2018 Q3 | 20.66 Million AUD | 2.52% |
| 2017 Q2 | 19.29 Million AUD | -0.95% |
| 2017 Q3 | 18.91 Million AUD | -1.95% |
| 2017 Q4 | 19.02 Million AUD | 0.59% |
| 2017 FY | 19.02 Million AUD | -7.88% |
| 2017 Q1 | 19.47 Million AUD | -5.7% |
| 2016 Q1 | 19.22 Million AUD | -4.78% |
| 2016 FY | 20.65 Million AUD | 2.3% |
| 2016 Q4 | 20.65 Million AUD | 7.67% |
| 2016 Q3 | 19.18 Million AUD | -2.93% |
| 2016 Q2 | 19.76 Million AUD | 2.8% |
| 2015 Q2 | 18.9 Million AUD | -1.31% |
| 2015 Q3 | 20.64 Million AUD | 9.24% |
| 2015 Q1 | 19.15 Million AUD | 6.42% |
| 2015 Q4 | 20.19 Million AUD | -2.21% |
| 2015 FY | 20.19 Million AUD | 12.2% |
| 2014 FY | 17.99 Million AUD | 13.5% |
| 2014 Q3 | 16.35 Million AUD | 6.77% |
| 2014 Q1 | 15.76 Million AUD | -0.59% |
| 2014 Q4 | 17.99 Million AUD | 10.06% |
| 2014 Q2 | 15.31 Million AUD | -2.85% |
| 2013 Q4 | 15.85 Million AUD | 12297.56% |
| 2013 Q2 | 383.73 Thousand AUD | -33.33% |
| 2013 Q1 | 575.6 Thousand AUD | 0.0% |
| 2013 FY | 15.85 Million AUD | 0.0% |
| 2013 Q3 | 127.91 Thousand AUD | -66.67% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q3 | 153.62 Thousand AUD | -60.0% |
| 2012 Q2 | 384.05 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2009 Q2 | 119.91 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 Q2 | 21.44 Thousand AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 2.912% |
| Adherium Limited | 93.2 Thousand AUD | -5233.924% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 27.07% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -5771.6% |
| Anteris Technologies Ltd | 2.33 Million AUD | -113.103% |
| Control Bionics Limited | 961.73 Thousand AUD | -416.927% |
| CardieX Limited | 3.22 Million AUD | -54.023% |
| Compumedics Limited | 6.97 Million AUD | 28.745% |
| Cochlear Limited | 243.7 Million AUD | 97.96% |
| CleanSpace Holdings Limited | 3.44 Million AUD | -44.256% |
| Cyclopharm Limited | 4.22 Million AUD | -17.604% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | -71.412% |
| Nova Eye Medical Limited | 3.34 Million AUD | -48.447% |
| HeraMED Limited | 260.65 Thousand AUD | -1807.297% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 68.338% |
| ImpediMed Limited | 1.14 Million AUD | -334.95% |
| InhaleRx Limited | 560.27 Thousand AUD | -787.329% |
| LBT Innovations Limited | 1.74 Million AUD | -185.226% |
| Micro-X Limited | 4.05 Million AUD | -22.601% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -6934.588% |
| PolyNovo Limited | 15.38 Million AUD | 67.676% |
| Respiri Limited | 1.17 Million AUD | -322.543% |
| SomnoMed Limited | 1.01 Million AUD | -389.313% |
| Uscom Limited | 989.27 Thousand AUD | -402.537% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -1492.628% |